
MBX Biosciences, Inc. Common Stock
USD60.28
+0.14 (+0.23%)
CEO
Peter Kent Hawryluk
IPO Date
2024-09-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$60.27
Prev. Close
$60.14
Day Low
$58.37
Day High
$61.17
52W Low
$9.63
52W High
$66.55
Market Cap
$2.02B
Volume
0.69M
| 16 Jan 2026 |
| Guggenheim |
| Buy |
| Buy |
| maintain |
| 19 Dec 2025 | Stifel | Buy | Buy | maintain |
| 10 Nov 2025 | Guggenheim | Buy | Buy | maintain |
| 24 Sept 2025 | Mizuho | Outperform | Outperform | maintain |
| 23 Sept 2025 | Oppenheimer | Outperform | Outperform | maintain |
| 23 Sept 2025 | Guggenheim | Buy | Buy | maintain |
| 10 Apr 2025 | Guggenheim | Buy | Buy | maintain |